16 Sep 2013
Harvard Business School Announces 2013 Kaplan Life Sciences Fellows
ShareBar

BOSTON—Two medical doctors, four engineers, three healthcare management professionals, and a healthcare technology researcher are the 2013 recipients of the Robert S. Kaplan Life Sciences Fellowship at Harvard Business School (HBS). All are entering first-year students in the School's MBA program.

Established in 2008 to encourage students with life sciences backgrounds and career interests to attend Harvard Business School, the Kaplan Fellowships enable HBS to award $20,000 each to ten incoming MBA students who meet these criteria. Credentials may include academic achievements, recognition from outside organizations, and professional accomplishments. Preferences are given to students who are planning careers in science-related businesses or organizations. Awards are for only the first year of the Harvard MBA Program and do not affect the recipient's eligibility for the School's need–based fellowships.

These awards were created through the generosity of Robert S. Kaplan, a member of the Harvard MBA Class of 1983 and former vice chairman of The Goldman Sachs Group, Inc., where he now serves as a senior director. He is currently the Martin Marshall Professor of Management Practice and Senior Associate Dean for External Relations at HBS. The Kaplan Fellowship Program reflects Harvard Business School's continuing commitment to trying to solve the array of problems facing the healthcare sector. In 2005, for example, HBS launched the Healthcare Initiative, a multidisciplinary program that brings together the extensive research, thought leadership, and interest in the business and management of healthcare that are now key parts of the School's agenda.

The 2013 Kaplan Fellows are:

  • Nathaniel Barbera, who spent the past two years with UMF Medial, a Johnstown, Penn.-based medical manufacturing company. He served as director of new product development and quality assurance, where he was responsible for refreshing over 50% of the existing product line. He graduated with a bachelor of science in mechanical engineering from the University of Notre Dame.
  • Elaine Besancon, MD, who was most recently an internal medicine and primary care resident at Brigham and Women’s Hospital in Boston. She also spent two years consulting with Merck, a pharmaceutical firm, where she worked on medication research and strategic planning projects. She graduated from Harvard College with a bachelor of science degree in neurobiology and graduated from Harvard Medical School in 2011.
  • Elizabeth Dykes, who has been spent the past six years with Merck in several departments including supply chain management, therapeutic proteins science and technology, and manufacturing development. Her responsibilities included leading a team to expedite product supply in emerging countries and developing and implementing new package design for existing products. She received a bachelor of science degree in chemical engineering from the University of Virginia.
  • Geoffrey Masterson, who was most recently employed as an assistant manager, customer experience, for the Johnson & Johnson Diabetes Care Franchise. Prior to this he was the pharmaceuticals distribution supervisor for J&J Pharmaceutical Services. He also served as a quality engineer for the global operations leadership development program at J&J Ethicon Inc. He has a dual degree in chemical engineering and materials science engineering from the University of California, Berkeley.
  • Miranda Shaw, who most recently served as a senior research engineer for Zimmer, Inc., a joint replacement technology firm in Warsaw, Indiana. She also recently co-founded and was general manager of Innovaject LLC, a product development and licensing company in the animal health industry, where she designed a drug delivery device to prevent and treat mastitis. She graduated with a bachelor’s of science degree in mechanical engineering from Ohio Northern University. She also holds a master’s in bioengineering and biomechanics from the University of Toledo and a Ph.D. in biomedical sciences, biomedical engineering and biomechanics from the Mayo Graduate School, College of Medicine, Mayo Clinic.
  • Piya Sircar, who has been a consultant with L.E.K. Consulting, working with pharma and biotech clients. She has also been involved with several biomedical startups in the Boston area that focus on developing novel vaccines and increasing global vaccine access. In addition, she has worked as a research associate at the Mayo Clinic and as a Howard Hughes Medical Institute Fellow at Yale University. She holds a bachelor’s degree in biochemistry from Mount Holyoke College, where she minored in computer science. She earned a Ph.D. in immunology from Harvard University in 2011.
  • Katelyn Staley, who has spent the last several years working as an engineer for W.L. Gore & Associates, a medical devices manufacturing company, where she helped oversee the design and manufacturing of new products. She graduated with a bachelor’s degree in mechanical engineering, with a minor in biomedical engineering and mathematics, from the University of Delaware.
  • Matthew Vestal, who is currently a neurosurgery resident at Brigham and Women’s Hospital and Children’s Hospital in Boston. He has also done research as a Howard Hughes Medical Institute Fellow, a Yale Student Research Fellow, and a Research Associate at the Johns Hopkins School of Medicine. As an undergraduate at the Johns Hopkins University, he majored in both neuroscience and public health. He earned MD and MHS (master’s in health sciences) from the Yale University School of Medicine.
  • Clay Wiske who was most recently a researcher at Brown University’s Tripathi Laboratory, focusing on portable diagnostic devices. He has also done research at the Miriam Hospital in Providence, RI, and the Nokia Research Center in Cambridge, England. He holds a bachelor’s degree in physics and pre-medical studies from Columbia University and an M.Phil. in Micro- and Nanotechnology from the University of Cambridge. He is currently an MD candidate at Brown University’s Alpert Medical School.
  • Hann-Shuin Yew, who comes to HBS from Stemcell Technologies in Vancouver, BC, where she was most recently a senior international marketing specialist, responsible for the global marketing strategy of over half the company’s products. She has a bachelor’s degree in molecular and cell biology, with a minor in economics, from Harvard. A dramaturg and script writer for the Bok Center Players during her undergraduate career, she won first place in the 2006 International Iris Chang Memorial Essay Competition.

Contacts

Cullen Schmitt
cschmitt+hbs.edu
617-495-6155